PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)
$154.33 6.09 (4.1082%)
Analysed PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) News Sources
FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
22-06-2026
yahoo.com
Palvella Shares Advance After FDA Grants Rolling Review for Rare Disease Therapy
22-06-2026
advfn.com
What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally
27-06-2026
fool.com
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
29-06-2026
yahoo.com
Palvella Therapeutics (PVLA) Submits Initial Module of NDA For QTORIN
15-07-2026
yahoo.com
Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing
30-07-2026
yahoo.com
Palvella Therapeutics Q2 Earnings Call Highlights
04-08-2026
marketbeat.com
Is Palvella Therapeutics (PVLA) Fully Valued Ahead Of QTORIN Approval?
08-08-2026
yahoo.com
Palvella (PVLA) Q2 2026 Earnings Call Transcript
11-08-2026
fool.com
Palvella Therapeutics Eyes 2027 QTORIN Approval as Rare-Disease Pipeline Expands
16-08-2026
marketbeat.com
What is the current price of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?
The current price of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is $154.33.
PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) since the previous trading day is $6.09.
PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) since the previous trading day is 4.1082%.
What is the most recent average sentiment score for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?
The most recent average sentiment score for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?
The most recent sentiment for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is .
SEC-8K** Filing Available For PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.